Document is current
Any future updates will be listed below
-
Authors
Sheinin, Ron https://orcid.org/0000-0001-9154-705X
Salomon, Koren https://orcid.org/0009-0008-2300-369X
Yeini, Eilam
Dulberg, Shai
Kaminitz, Ayelet
Satchi-Fainaro, Ronit https://orcid.org/0000-0002-7360-7837
Sharan, Roded
Madi, Asaf https://orcid.org/0000-0003-3441-3228
- License Information
-
More Information
Article History
Received: 17 October 2023
Accepted: 28 May 2024
First Online: 10 June 2024
Competing interests
: R.S.-F. is a board member at TEVA Pharmaceuticals Ltd. And receives unrelated research funding from Merck KGaA. All other authors have no competing interests to declare.
